Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ER ChiP-Seq Mcf7 10nM E2

ABSTRACT: ER ChiP-Seq Mcf7 10nM E2

PROVIDER: PRJNA480204 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7497751.fastq.gz	Fastqsanger.gz
	SRR7497752.fastq.gz	Fastqsanger.gz
	SRR7497753.fastq.gz	Fastqsanger.gz
	SRR7497754.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

ER ChiP-Seq Mcf7 10nM E2

Project description:Cells starved 3 days in phenol red free DMEM with 10% charcoal dextran treated FBS, then treated for 45min with 10nM E2

2018-07-10 | GSE116768 | GEO

ChIP-Seq analysis of ER binding sites in MCF7 breast cancer cells

Project description:Estrogen Receptor (ER) is a hormonal transcription factor that plays important roles in breast cancer. It functions primarily through binding to the regulatory regions of target genes containing the consensus ERE motifs. In order to identify ER target genes and re-define the ERE motifs we performed ChIP-Seq analysis of ER in MCF7 breast cancer cell line. Applying a novel computational algorithm named Hybrid Motif Sampler (HMS), specifically designed for TFBS motif discovery in ChIP-Seq data, we were able to detect an improved ERE motif and reveal intra-motif dependency especially in neighboring base pairs. MCF7 cells were grown in starving medium (RPMI with 5% FCS) for 3 days prior to the treatment with 10 nM β-estradiol or vehicle control for 45 minutes. ChIP was done using an anti-ER antibody in both the ethl-treated and the E2-treated cells. ChIP-Seq sample prep and sequencing were done following the manufacture's protocol using the Genome Analyzer (Illumina). The read files were analyzed using ethl-treated as control for E2-treated, leading to one final peak file.

2010-02-01 | E-GEOD-19013 | biostudies-arrayexpress

ER-RIME in wt-MCF7 and MCF7-LTED

Project description:Wild type (wt) MCF7 cells, modelling breast cancer at primary diagnosis, were cultured in phenol red-free RPMI supplemented with 10% FBS and 1nM estradiol (E2). Long-term oestrogen deprived (LTED) cell lines, which model resistance to endocrine therapy, were cultured in phenol red-free RPMI in the absence of exogenous E2 and supplemented with 10% dextran charcoal-stripped bovine serum (DCC). Samples were harvested at baseline and at the point of resistance (LTED). In order to do comparative analysis in the ER-interactome of wt-MCF7 and MCF7-LTED cells, ER-RIME (rapid immunoprecipitation mass spectrometry of endogenous proteins) was conducted in these cells.

2020-07-13 | PXD004648 | Pride

ERalpha ChIP-chip from HeLA-ER cells treated with E2

Project description:We are studying the mechanisms by which the estrogen receptor, ERalpha, is recruited to and regulates genes with a non-direct DNA binding. We performed ChIP-chip for ERalpha in E2 treated HeLa-ER cells, and looked at 19000 RefSeq genes to determine binding patterns of the receptor at promoters. The experiment was performed in duplicate. ChIP-chip biological replicates for Eralpha in E2 treated HeLa-ER cells are included.

2011-02-22 | E-GEOD-22099 | biostudies-arrayexpress

MAF Amplification licenses Estrogen Receptor α to Drive Breast Cancer Metastasis [ER ChIP-seq]

Project description:We performed genome-wide mapping of estrogen receptor (ER) binding sites in control and MAF-overexpressing MCF7 cells to assess the consequences of estrogen (E2) stimulation upon metastasic MAF expression. To this end, we cultured MCF7 cells in hormone-deprived (HD) medium for 72 h and then E2 or vehicle was added for 1h prior to chromatin immunoprecipitation (ChIP). Samples were generated in triplicate. We report that E2 induces extensive ER recruitment to chromatin and that ER-binding is gained and expanded upon MAF overexpression.

2023-09-15 | GSE210604 | GEO

Genome-wide maps of ER and γH2AX binding and transcriptomes in BRCA1-deficient cells with E2 treatment

Project description:The goal of this study is to find out the relationship between ER-mediated transcription and DNA damage induced by estrogen(E2) and BRCA1 deficiency in MCF7. The DNA damage is marked by chromatin binding of γH2AX using ChIP-seq.

2022-04-07 | GSE200154 | GEO

ERalpha ChIP-chip from HeLA-ER cells treated with E2

2011-02-22 | GSE22099 | GEO

Genome wide DRIP-seq in E2 stimulated MCF7 cells

Project description:We mapped the location of RNA-DNA hybrids in hormone-starved MCF7 breast cancer cells treated with the hormone estradiol (E2.) E2 is a potent transcriptional activator, and causes proliferation in hormone starved cells. We find a significant induction of hybrids at genes known to be regulated by the estrogen receptor.

2016-08-23 | GSE81851 | GEO

ChIP-Seq analysis of ER binding sites in MCF7 breast cancer cells

2010-02-01 | GSE19013 | GEO

H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1

Project description:H3K27Ac ChIP-seq in MCF7 Y537S ER mutant cells RNAseq analysis of MCF7 Y537S ER mutant cells treated with veh and THZ1

2018-02-15 | GSE106552 | GEO